Ran Nussbaum Transaction History

Date Transaction Value Shares Traded Form
Jan 22 2021
SELL
Disposition due to a tender of shares in a change of control transaction
-
1,576,881

Also insider at

KROS
Keros Therapeutics, Inc. Healthcare
URGN
UroGen Pharma Ltd. Healthcare
ELOX
Eloxx Pharmaceuticals, Inc. Healthcare
RN

Ran Nussbaum

Director
Princeton, NJ

Track Institutional and Insider Activities on PRVL

Follow Prevail Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRVL shares.

Notify only if

Insider Trading

Get notified when an Prevail Therapeutics Inc. insider buys or sells PRVL shares.

Notify only if

News

Receive news related to Prevail Therapeutics Inc.

Track Activities on PRVL